Related Experiment Video For bladder carcinoma
Updated: Aug 19, 2026
Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
Rapidly Progressive Retroperitoneal Dissemination of Plasmacytoid Urothelial Carcinoma Presenting With Multiorgan
Mahito Atsuta1,2, Naoki Uchida1,2, Hirokazu Kagawa1,2
1Department of Urology The Jikei University Kashiwa Hospital Chiba Japan.
Introduction:
Plasmacytoid urothelial carcinoma (PUC) is a rare, aggressive subtype of bladder cancer characterized by diffuse infiltrative growth and a propensity for peritoneal and retroperitoneal dissemination.
Case Presentation:
A patient with muscle-invasive bladder cancer (cT3N1M0) was diagnosed with conventional high-grade urothelial carcinoma without subtype histology on transurethral resection. After neoadjuvant gemcitabine-cisplatin chemotherapy, robot-assisted radical cystectomy with intracorporeal neobladder reconstruction was performed. Final pathological examination revealed PUC (pT4aN2). Within weeks after surgery, the patient developed sequential retroperitoneal fluid accumulation, bilateral hydronephrosis, duodenal obstruction, and biliary obstruction, suggesting rapid diffuse retroperitoneal progression. Enfortumab vedotin plus pembrolizumab was initiated; however, the disease progressed aggressively, and the patient died on postoperative day 80.
Conclusion:
PUC may evade detection on initial TUR and can progress rapidly through diffuse retroperitoneal dissemination even after radical cystectomy. Early postoperative, unexplained multiorgan obstructive findings should raise suspicion of occult progression and prompt timely initiation of systemic therapy.
